Viatris (VTRS) Goodwill & Intangibles (2019 - 2026)
Viatris' (VTRS) quarterly Goodwill & Intangibles came in at $21.2 billion in Q1 2026, down 8.43% year-on-year from $23.1 billion in Q1 2025, and down 3.12% quarter-over-quarter from $21.9 billion in Q4 2025.
Viatris (VTRS) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Viatris' Goodwill & Intangibles history runs 8 years deep, the most recent figure standing at $21.2 billion for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 8.43% year-over-year to $21.2 billion in Q1 2026; TTM through Mar 2026 was $21.2 billion, a 8.43% decrease from a year earlier, with the FY2025 full-year figure at $21.9 billion, down 16.59% from the prior year.
- Goodwill & Intangibles eased to $21.2 billion in Q1 2026 per VTRS's latest filing, from $21.9 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $36.2 billion in Q1 2022 and bottomed at $21.2 billion in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $28.8 billion (2024), against an average of $28.6 billion.
- Across the five-year window, Goodwill & Intangibles fell 4.56% in 2023 and fell 19.78% in 2025, its largest moves.
- Year by year, Goodwill & Intangibles stood at $33.0 billion in 2022, then declined by 12.06% to $29.0 billion in 2023, then declined by 9.79% to $26.2 billion in 2024, then fell by 16.59% to $21.9 billion in 2025, then dropped by 3.12% to $21.2 billion in 2026.
- Per Business Quant, the three latest VTRS Goodwill & Intangibles figures stand at $21.2 billion (Q1 2026), $21.9 billion (Q4 2025), and $22.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.17 Bn |
| Dec 31, 2025 | 21.86 Bn |
| Sep 30, 2025 | 22.45 Bn |
| Jun 30, 2025 | 23.07 Bn |
| Mar 31, 2025 | 23.12 Bn |
| Dec 31, 2024 | 26.20 Bn |
| Sep 30, 2024 | 27.54 Bn |
| Jun 30, 2024 | 27.74 Bn |
| Mar 31, 2024 | 28.83 Bn |
| Dec 31, 2023 | 29.05 Bn |
| Sep 30, 2023 | 31.56 Bn |
| Jun 30, 2023 | 32.62 Bn |
| Mar 31, 2023 | 33.27 Bn |
| Dec 31, 2022 | 33.03 Bn |
| Sep 30, 2022 | 33.07 Bn |
| Jun 30, 2022 | 34.62 Bn |
| Mar 31, 2022 | 36.23 Bn |
| Dec 31, 2021 | 38.25 Bn |
| Sep 30, 2021 | 39.16 Bn |
| Jun 30, 2021 | 39.85 Bn |